168 related articles for article (PubMed ID: 20570932)
41. Selection of peptide ligands binding to the basolateral cell surface of proximal convoluted tubules.
Audigé A; Frick C; Frey FJ; Mazzucchelli L; Odermatt A
Kidney Int; 2002 Jan; 61(1):342-8. PubMed ID: 11786117
[TBL] [Abstract][Full Text] [Related]
42. Construction of a human Fab phage display library from antibody repertoires of osteosarcoma patients.
Dantas-Barbosa C; Brígido MM; Maranhão AQ
Genet Mol Res; 2005 Jun; 4(2):126-40. PubMed ID: 16110435
[TBL] [Abstract][Full Text] [Related]
43. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
[TBL] [Abstract][Full Text] [Related]
44. In vitro high throughput phage display selection of ovarian cancer avid phage clones for near-infrared optical imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2014; 17(10):859-67. PubMed ID: 25360673
[TBL] [Abstract][Full Text] [Related]
45. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
[TBL] [Abstract][Full Text] [Related]
46. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer.
Liang S; Lin T; Ding J; Pan Y; Dang D; Guo C; Zhi M; Zhao P; Sun L; Hong L; Shi Y; Yao L; Liu J; Wu K; Fan D
J Mol Med (Berl); 2006 Sep; 84(9):764-73. PubMed ID: 16763842
[TBL] [Abstract][Full Text] [Related]
47. [Preliminary screening and identification of a peptide that binds specifically to gastric cancers cells with high metastasis to peritoneum].
Bai FH; Wang J; Zhao PT; Cao SS; Lei T; Li Y; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):659-63. PubMed ID: 16681920
[TBL] [Abstract][Full Text] [Related]
48. In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo.
McGuire MJ; Samli KN; Johnston SA; Brown KC
J Mol Biol; 2004 Sep; 342(1):171-82. PubMed ID: 15313615
[TBL] [Abstract][Full Text] [Related]
49. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer.
Bai F; Liang J; Wang J; Shi Y; Zhang K; Liang S; Hong L; Zhai H; Lu Y; Han Y; Yin F; Wu K; Fan D
J Mol Med (Berl); 2007 Feb; 85(2):169-80. PubMed ID: 17043801
[TBL] [Abstract][Full Text] [Related]
51. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
[TBL] [Abstract][Full Text] [Related]
52. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
[TBL] [Abstract][Full Text] [Related]
53. Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
Campanile C; Arlt MJ; Krämer SD; Honer M; Gvozdenovic A; Brennecke P; Fischer CR; Sabile AA; Müller A; Ametamey SM; Born W; Schibli R; Fuchs B
J Nucl Med; 2013 Aug; 54(8):1362-8. PubMed ID: 23801674
[TBL] [Abstract][Full Text] [Related]
54. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.
Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR
J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861
[TBL] [Abstract][Full Text] [Related]
55. In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe.
Miller SJ; Joshi BP; Feng Y; Gaustad A; Fearon ER; Wang TD
PLoS One; 2011 Mar; 6(3):e17384. PubMed ID: 21408169
[TBL] [Abstract][Full Text] [Related]
56. Screening for novel peptides specifically binding to the surface of ectopic endometrium cells by phage display.
Linzhi Y; Dan C; Arhin SK; Ledan W; Wenju L; Jieqiang L
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):36-40. PubMed ID: 30213287
[TBL] [Abstract][Full Text] [Related]
57. Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
Tsukahara T; Emori M; Murata K; Hirano T; Muroi N; Kyono M; Toji S; Watanabe K; Torigoe T; Kochin V; Asanuma H; Matsumiya H; Yamashita K; Himi T; Ichimiya S; Wada T; Yamashita T; Hasegawa T; Sato N
J Biol Chem; 2014 Aug; 289(32):22035-47. PubMed ID: 24962571
[TBL] [Abstract][Full Text] [Related]
58. (68)Ga-labeled phage-display selected peptides as tracers for positron emission tomography imaging of Staphylococcus aureus biofilm-associated infections: Selection, radiolabelling and preliminary biological evaluation.
Nielsen KM; Kyneb MH; Alstrup AK; Jensen JJ; Bender D; Schønheyder HC; Afzelius P; Nielsen OL; Jensen SB
Nucl Med Biol; 2016 Oct; 43(10):593-605. PubMed ID: 27474962
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the RGD Motif-Containing α
Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
[TBL] [Abstract][Full Text] [Related]
60. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
